The life sciences and biotechnology company posted revenue of $21.3 million in the period. In the final minutes of trading on Monday, the company's ...
News
- Enzo Biochem: Fiscal 1Q Earnings Snapshot
- Generon Presented Positive Phase III Results From a Double-Blind, Placebo Controlled-Clinical ...
SHANGHAI--(BUSINESS WIRE)--Dec 8, 2018--Generon BioMed Holding ... announced today at the annual San Antonio Breast Cancer Symposium ...
- Meridian Bioscience (VIVO) Shareholder Brown Capital Management Cut Its Stake by $5.16 Million ...
Brown Capital Management Llc decreased its stake in Meridian Bioscience Inc ... Meridian Bioscience, Inc. (NASDAQ:VIVO) has risen 11.66% since ... at San Antonio Breast Cancer Symposium – Nasdaq” published on November 14 ...
- Initial public offerings scheduled to debut next week
Business: Principal biotech developing immunotherapies for solid tumors. Tencent Music Entertainment - Shenzhen, China, 82 million shares, priced ...
- Is It Time to Start Worrying About the Stock Market?
Medical device maker Boston Scientific Corp. up 43 percent this year, was down 3.51 precent today and biotech firm Alexion Pharmaceuticals fell 4.49 ...